CFDE Data Portal | Search RPS12P31

	Label	Description
	RPS12P31 associations Collection (Entity type)	Associations for RPS12P31_associations
	RPS12P31 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPS12P31 Gene (Entity type)	ENSG00000242325 - ribosomal protein S12 pseudogene 31
	GSE119369 H10 inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172409 dopamine neuron 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE160001 GSE160670 lapatinib SK-BR-3 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Spleen 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Esophagus 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx

RPS12P31 associations

Associations for RPS12P31_associations

RPS12P31 associations.tsv

A file from IDG as part of the Harmonizome project

RPS12P31

ENSG00000242325 - ribosomal protein S12 pseudogene 31

GSE119369 H10 inhibition 1 v 5 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 3 human dn

A Gene Set from LINCS

GSE172409 dopamine neuron 1 v 4 human up

A Gene Set from LINCS

GSE160001 GSE160670 lapatinib SK-BR-3 1 v 2 human dn

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 7 human dn

A Gene Set from LINCS

GTEx Spleen 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Esophagus 20-29 vs 40-49 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.